# Infants/young children with Cov19
Padiatric COVID-19 project

# Study design for scRNAseq: 
scRNA-seq profiling of PBMC from 26 SARS-Cov-2 infected infants (10 asymptomatic, 11 mild and 5 severe patients), as well as 14 healthy matched controls
Antibody titers (anti-SARS and IFN)

# Technology 
10X Genomics V3

# Other mesurments 
Serum protein quatification (Olink and Biolegend) for IFN and Inflammation pathways
Antibody titers (anti-SARS  and anti-IFN)
